Health Canada has issued a Notice of Compliance with conditions (NOC/c) for TECVAYLI™ (teclistamab injection)
The Janssen Pharmaceutical Companies of Johnson & Johnson announced today that Health Canada has issued a...
Read moreThe Janssen Pharmaceutical Companies of Johnson & Johnson announced today that Health Canada has issued a...
Read moreMyeloma Canada, along with thousands from the global hematology community, had the privilege of following...
Read moreMyeloma Canada is pleased to share that funding for Sarclisa (isatuximab) is officially available in two...
Read moreRapid Novor Inc., the world’s leader in mass spectrometry (MS)-based antibody protein sequencing, announc...
Read moreIn this phase 1/2 study, carfilzomib was added to high-dose melphalan conditioning prior to autologous st...
Read moreResearchers have long known that moderate exercise has a beneficial impact on the body’s response to infl...
Read moreJoin our community and sign up for our newsletter.